On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Crystal structures of P450s
- Structures of P450s
- CYPs 3A4, 2A6 and 101
- CYP2C5/diclofenac complex
- Targeting of P450s to membranes
- Microsomal P450s for crystall.
- P450-membrane interactions
- Proximal face of P450 2C5
- Role of heme in O2 reduction
- P450 heme binding site: CYP101 (1)
- P450 heme binding site: CYP101 (2)
- Substrate binding in CYP2C5
- Family 2 P450s
- P450s 2C8, 2C5 and 2A6
- Comparison of CYP2C8/CYP2C5
- Active site cavities - size/shape diff.
- Active site shape and volume
- Size discrimination
- CYP2C5 - DFC vs. DMZ binding
- DMZ/DFC complexes of CYP2C5
- CYP2B4 - open/closed confo. (1)
- CYP2B4 - open/closed confo. (2)
- P450 flexibility
- CYP2A6
- Coumarin bound to CYP2A6
- Substrate binding to P450s
- CYP2C9 substrates
- WT/mutant CYP2C9 conformations
- CYP2C9 complexes - 1OG5/1R9O
- Flurbiprofen contacts in CYP2C9
- S-warfarin binding to CYP2C9
- Small substrates - large active sites
- Flurbiprofen complex of CYP2C9
- CYP3A4 substrates
- Structures of CYP 3A4 and 2C8
- In silico docking of testosterone
- CYP3A4 structures
- Metyrapone bound to CYP3A4
- Interfaces of CYP 2C8 and 3A4
- CYP2C8 substrates
- Montelukast bound to CYP2C8
- Summary
Topics Covered
- Introduction to CYP450 architecture
- Shared structural features
- Catalytic mechanism
- Redox partner interactions
- Membrane topology
- Multiple modes of substrate binding and oxidation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Johnson, E. (2007, October 1). Crystal structures of drug-metabolizing P450 monooxygenases [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/IRAM9877.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Eric Johnson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.